Had a discussion with my Hema last week about starting low dose Danazol (50 mg per day) and tapering out of Promacta (12.5 mg). Note that this is the lowest dose available for both drugs. If all goes well I'll take Danazol all of 2018. Studies show that one has to take the drug for a year to achieve a durable multi-year remission. First dose should be Monday and will take both Danazol and Promacta for 4 weeks and then check counts. Doc expects a noticeable increase at around 6 weeks. For reference, the range of response times is 0 to 6 months. But that statistic is for all responding ITP'ers and a much higher starting dose level.
As I've mentioned before, my insurance co has declined to pay for Danazol when one has ITP. They prefer to pay $4,000 per month for Promacta over the $35 per month for Danazol. I have leveraged this fact for 2017.
The reason I am trying Danazol is that my own steroid and IVIG response follows row '3' in my
ITP treatments table.
Recall that this table was derived by me reading a large number of reported responses (a retrospective study) from members of this forum and summarizing the results of successes stories. For row 3, PDSA members have reported achieving remission with Danazol treatments in the past. Also worth noting, no row 3 (only) member has ever reported remission with Rituxan, Promacta, Nplate, or even IVIG - which they respond strongly too.
Although the normal starting dose of Danazol is much higher,
this study
suggests a strong Danazol responder can start on 50 mg and still achieve remission. Apparently strong responders can titrate down to 50 mg so a strong responder can start out on 50 mg without issue.
A little bit about Danazol. I had read that one of the things Danazol does is increase one's Thrombopoietin (TPO) production. My Hema confirmed this. Recall that TPO causes the body to produce platelets. With that it makes more sense why Danazol works well with a row 3 response. Row 3 folks are very sensitive to Promacta. Thus they are very sensitive Danazol because of the TPO dynamic.
Danazol also affects the immune system in several ways.
Here is a study
that does a good job of enumerating them. See paragraph 3.2.
Some things in the study worth commenting on. Quoting:
"It induces a decrease in Fcγ receptor expression on monocytes that could lead to a decrease in platelet phagocytosis"
This sounds like it works a bit like IVIG.
"Moreover, danazol promotes lymphocyte differentiation into regulatory T lymphocytes"
This sound like it helps to put regulatory balance into the self / non-self identification of TPO and/or platelets. Perhaps this aspects is how long lasting remissions are possible with Danazol.
One last tidbit. AFAIK, this low of a dose is safe for women as well.